Corporate Communication Specialist
Job Description:
Oversee and execute corporate social media content across official channels.
Drive process improvement initiatives related to social media and digital communication workflows, including approval and escalation processes.
Lead corporate branding and communication for external exhibitions and events.
Manage corporate branding booths for key institutional events, including but not limited to MOI, MOH, BPOM, other CorCom and stakeholder events.
Develop and manage the corporate communication calendar, ensuring timely execution of planned communication activities.
Support communication-related aspects of AGMS, including corporate branding and visual materials.
Participating in special corporate communication projects.
Job Requirements:
University degree in any discipline, preferably Communication, Mass Communication, or a related field.
Min. 3 years of relevant experience in corporate communication, public relations, or related roles.
Experience from pharmaceutical and/or FMCG industries is preferred due to regulatory and reputational exposure.
Excellent communication and interpersonal skills, with the ability to work across multiple stakeholders.
Solid business acumen and problem‑solving skills.
Good analytical and creative thinking capability to support content development and communication planning.
Demonstrated capability to collaborate effectively in a matrix organization and coordinate with internal teams and external service providers.
Strong awareness of regulatory frameworks, guidelines, and compliance requirements, particularly relevant to communication in a regulated and public‑company environment.
Understanding of how corporate communication supports compliance, disclosure principles, and reputation management.
Profil perusahaan
PT Darya-Varia Laboratoria Tbk ("Darya-Varia" or "the Company") is a long-established pharmaceutical company in Indonesia that first commenced its operations in 1976. Upon becoming a public company in 1994, it acquired PT Pradja Pharin (Prafa) in 1995, and proceeded to develop a wide range of Prescription and Consumer Health products. In July 2014, Darya-Varia merged with Prafa. Darya-Varia operates two world-class manufacturing facilities, one in Gunung Putri and one in Citeureup, Bogor, both of which are ASEAN current Good Manufacturing Practice (cGMP) certified. The two plants are focused on manufacturing the Company's own brands, as well as toll manufacturing products for national and multinational principals, both for local and export markets. The Darya-Varia Plant in Gunung Putri specializes in manufacturing soft gelatin capsules and liquid products, while the Darya-Varia Plant in Citeureup concentrates on the manufacturing of sterile injections and solids. The Company also toll manufactures with its affiliate, PT Medifarma Laboratories, at Cimanggis Plant, Depok. In 2013, the Company obtained halal certification for NATUR-E and HOBAT Capsules, its animal based gelatin products, marking a first halal certified supplement for a pharmaceutical company in Indonesia. In line with its mission to "build a healthier Indonesia one person at a time", Darya-Varia produces high quality products for both Consumer Health and Ethical product lines, building strong, respected brands that are recognized throughout Indonesia. By following a consistent and relationship-driven engagement approach, the Company is moving to achieve its vision to be a top-five pharmaceutical company in Indonesia. Currently 92.66% of Darya-Varia shares is owned by Blue Sphere Singapore Pte. Ltd. (BSSPL), an affiliate of United Laboratories, Inc. (Unilab).Unilab, the Philippines' largest pharmaceutical company, was established in 1945 and now has a large network of Asian affiliates including operations in Indonesia, Vietnam, Myanmar, Thailand, Malaysia, Singapore, Laos, Cambodia and China.
1,001-5,000 employees
PT Darya-Varia Laboratoria Tbk ("Darya-Varia" or "the Company") is a long-established pharmaceutical company in Indonesia that first commenced its operations in 1976. Upon becoming a public company in 1994, it acquired PT Pradja Pharin (Prafa) in 1995, and proceeded to develop a wide range of Prescription and Consumer Health products. In July 2014, Darya-Varia merged with Prafa.